Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

(1) Care and maintenance to reduce vascular access complications. (2) Care and maintenance to reduce vascular access complications 2008 supplement.

BIBLIOGRAPHIC SOURCE(S)

  • Registered Nurses' Association of Ontario (RNAO). Care and maintenance to reduce vascular access complications. Guideline supplement. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2008. 7 p. [21 references]


  • Registered Nurses' Association of Ontario (RNAO). Care and maintenance to reduce vascular access complications. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Apr. 88 p. [112 references]

GUIDELINE STATUS

This is the current release of the guideline.

** REGULATORY ALERT **

FDA WARNING/REGULATORY ALERT

Note from the National Guideline Clearinghouse: This guideline references a drug(s) for which important revised regulatory and/or warning information has been released.

  • February 28, 2008, Heparin Sodium Injection: The U.S. Food and Drug Administration (FDA) informed the public that Baxter Healthcare Corporation has voluntarily recalled all of their multi-dose and single-use vials of heparin sodium for injection and their heparin lock flush solutions. Alternate heparin manufacturers are expected to be able to increase heparin production sufficiently to supply the U.S. market. There have been reports of serious adverse events including allergic or hypersensitivity-type reactions, with symptoms of oral swelling, nausea, vomiting, sweating, shortness of breath, and cases of severe hypotension.

BRIEF SUMMARY CONTENT

 ** REGULATORY ALERT **
 RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

Note from the National Guideline Clearinghouse (NGC) and the Registered Nurses' Association of Ontario (RNAO): In December 2007, the RNAO) reviewed the current practice recommendations for this topic. A review of the most recent studies and relevant guidelines published since the development of the original guideline does not support changes to the recommendations. However, the panel has identified several inaccuracies in the original guideline as well as several gaps in the available evidence, which are outlined below (marked as "updated in 2008").

The levels of evidence supporting the recommendations (Ia, Ib, IIa, IIb, III, IV) are defined at the end of the "Major Recommendations" field.

Practice Recommendations

Site Selection: Peripheral

Recommendation 1.0

Nurses will select a peripheral insertion site appropriate for the required therapy and with the least risk of complication.

(Level of Evidence = IV)

Site and Catheter Care: Safety/Infection Prevention Control

Recommendation 2.0

Nurses will prevent the spread of infection by following routine practices and using additional precautions.

(Level of Evidence = IV)

Skin Antisepsis

Recommendation 3.0 (Updated in 2008)

Nurses will consider the following factors when performing catheter site care using aseptic technique:

  • Catheter material (composition)
  • Antiseptic solution
  • Client's tolerance (skin integrity, allergies, pain, sensitivity, and skin reaction)

(Level of Evidence = IV)

Although the evidence supports the original recommendation, the panel would like to include an alert:

Aseptic technique must include choice of solution, use of friction, and adequate contact time in order to be considered an effective use of technique. Please consult your institutional policy or infection control policies for more details.

Tip Placement

Recommendation 4.0 (Updated in 2008)

Nurses will not use the central venous access device (CVAD) until tip placement has been confirmed.

(Level of Evidence = IV)

Although the evidence supports the original recommendation, the panel would like to include an alert:

Anatomical tip location must be documented by a radiologist/attending physician following insertion, and this documentation must be accessible to all the client's health care providers throughout the continuum of care.

Please note: the original discussion of the evidence referred to an illustration (Appendix D of the original guideline document) which is inaccurate; please refer to Appendix B of the 2008 supplement for a revised visual representation of correct tip placement.

Dressings

Recommendation 5.0

Nurses will consider the following factors when selecting and changing venous access device (VAD) dressings:

  • Type of dressing
  • Frequency of dressing changes
  • Client's choice, tolerance, and lifestyle

(Level of Evidence = IV)

Securement

Recommendation 6.0

Nurses must stabilize the VAD in order to:

  • Promote assessment and monitoring of the vascular access site
  • Facilitate delivery of prescribed therapy
  • Prevent dislodgement, migration, or catheter damage

(Level of Evidence = III)

Patency/Flushing/Locking

Recommendation 7.0 (Updated in 2008)

Nurses will maintain catheter patency using flushing and locking techniques.

(Level of Evidence = IV)

See Appendix C of the 2008 supplement for detailed and updated flushing and locking interventions.

Recommendation 8.0

Nurses will know what client factors, device characteristics, and infusate factors can contribute to catheter occlusion in order to ensure catheter patency for the duration of the therapy.

(Level of Evidence = IV)

Occlusion

Recommendation 9.0

Nurses will assess and evaluate vascular access devices for occlusion in order to facilitate treatment and improve client outcomes.

(Level of Evidence = IV)

Blood Withdrawal

Recommendation 10.0

Nurses will minimize accessing the central venous access device (CVAD) in order to reduce the risk of infection and nosocomial blood loss.

(Level of Evidence = IV)

Add-Ons

Recommendation 11.0

Nurses will change all add-on devices a minimum of every 72 hours.

(Level of Evidence = IV)

Documentation

Recommendation 12.0

Nurses will document the condition of vascular access devices including:

  • The insertion process
  • Site assessment
  • Functionality

(Level of Evidence = III)

Client Education

Recommendation 13.0

Nurses will help clients to attain the highest level of independence through client education.

(Level of Evidence = IV)

Education Recommendations

Recommendation 14.0

The principles and practice of infusion therapy should be included in the basic education curriculum, be available as continuing education, be provided in orientation to new employees, and be made available through continuing professional development opportunities.

(Level of Evidence = IV)

Recommendation 15.0

Schools of Nursing will include Registered Nurses' Association of Ontario (RNAO) best practice guidelines Assessment and Device Selection for Vascular Access and Care and Maintenance to Reduce Vascular Access Complications as reference material for core curricula.

(Level of Evidence = IV)

Organization & Policy Recommendations

Recommendation 16.0

Health care organizations will have policies that address components of vascular access therapy in order to ensure positive client outcomes.

(Level of Evidence = IV)

Recommendation 17.0

Health care organizations, in collaboration with their infection control teams, will monitor complications of infusion therapy and use data to employ risk reduction strategies.

(Level of Evidence = IV)

Recommendation 18.0

Health care organizations will implement the use of safety engineered devices and equipment to reduce the nurse's risk of sharps injuries that can lead to blood borne diseases. The organization's risk management program will monitor assessment of these practices and incidents.

(Level of Evidence = III)

Recommendation 19.0 (Updated in 2008)

Health care organizations have access to infusion therapy nursing expertise to support optimal vascular access outcomes.

(Level of Evidence = III)

Note: Although the evidence supports the original recommendation, the panel would like to emphasize the importance of health care organizations having access to credentialed infusion therapy nurses to support optimal vascular access outcomes.

Recommendation 20.0

Nursing best practice guidelines can be successfully implemented only where there are adequate planning, resources, organizational and administrative support, as well as appropriate facilitation. Organizations may wish to develop a plan for implementation that includes:

  • An assessment of organizational readiness and barriers to education.
  • Involvement of all members (whether in a direct or indirect supportive function) who will contribute to the implementation process.
  • Dedication of a qualified individual to provide the support needed for the education and implementation process.
  • Ongoing opportunities for discussion and education to reinforce the importance of best practices.
  • Opportunities for reflection on personal and organizational experience in implementing guidelines.

In this regard, RNAO (through a panel of nurses, researchers, and administrators) has developed the Toolkit: Implementation of Clinical Practice Guidelines based on available evidence, theoretical perspectives, and consensus. The Toolkit is recommended for guiding the implementation of the RNAO guideline Care and Maintenance to Reduce Vascular Access Complications.

(Level of Evidence = IV)

Definitions:

Levels of Evidence

Ia Evidence obtained from meta-analysis or systematic review of randomized controlled trials

Ib Evidence obtained from at least one randomized controlled trial

IIa Evidence obtained from at least one well-designed controlled study without randomization

IIb Evidence obtained from at least one other type of well-designed quasi-experimental study without randomization

III Evidence obtained from well-designed non-experimental descriptive studies, such as comparative studies, correlation studies, and case studies

IV Evidence obtained from expert committee reports or opinions and/or clinical experiences of respected authorities

CLINICAL ALGORITHM(S)

An algorithm is provided in the original guideline document for troubleshooting catheter occlusion.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The type of evidence is identified and graded for each recommendation (see "Major Recommendations" field).

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Registered Nurses' Association of Ontario (RNAO). Care and maintenance to reduce vascular access complications. Guideline supplement. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2008. 7 p. [21 references]


  • Registered Nurses' Association of Ontario (RNAO). Care and maintenance to reduce vascular access complications. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2005 Apr. 88 p. [112 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

2005 Apr (addendum released 2008)

GUIDELINE DEVELOPER(S)

Registered Nurses' Association of Ontario - Professional Association

SOURCE(S) OF FUNDING

Funding was provided by the Ontario Ministry of Health and Long-Term Care.

GUIDELINE COMMITTEE

Not stated

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Review Panel Members

Susanne Nelson, RN, BScN, MN, CVAA(C)
Review Chair
CNS – Vascular Access
University Health Network
Toronto, Ontario

Sharon Armes, RN, CVAA(C)
Senior Clinical Education Coordinator
Bard Canada Inc.
Mississauga, Ontario

Adrienne Austin, RN, BScN, CVAA(C)
Clinical Manager, Vascular Access Therapy
Hamilton Health Sciences Centre
Hamilton, Ontario

Nan Clark, RN, CVAA(C), CON(C), CCHN(C)
International Community Consultant
Saint Elizabeth Health Care
Markham, Ontario

Glenda Hicks, RN, BScN
Nurse Clinician
Critical Care Program
Sudbury Regional Hospital
Sudbury, Ontario

Julia Johnston, RN, BScN, MN
Advanced Practice Nurse, Palliative Care Program
Trillium Health Centre
Mississauga, Ontario

Jenny Oey Chung, RN, BScN, MN
Program Manager
International Affairs and Best
Practice Guidelines Programs
Registered Nurses' Association of Ontario
Toronto, Ontario

Kris Paton, RN, CVAA(C)
Clinical Leader, Vascular Access Therapy
Hamilton Health Sciences Centre
Hamilton, Ontario

Sharon Rodkin, RN, CVAA(C)
Manager, Clinical Consulting
Baxter Corporation
Mississauga, Ontario

Lisa Valentine, RN, BScN, MN
Clinical Nurse Specialist/Case Manager
Regional Stroke Program – North East GTA
Sunnybrook Health Sciences Centre
Toronto, Ontario

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

The Registered Nurses' Association of Ontario (RNAO) received funding from the Ministry of Health and Long-Term Care (MOHLTC). This guideline was developed by a panel of nurses and researchers convened by the RNAO and conducting its work independent of any bias or influence from the MOHLTC.

GUIDELINE STATUS

This is the current release of the guideline.

GUIDELINE AVAILABILITY

2005 Guideline

Electronic copies: Available in Portable Document Format (PDF) from the Registered Nurses' Association of Ontario (RNAO) Web site.

2008 Supplement

Electronic copies: Available in Portable Document Format (PDF) from the RNAO Web site.

Print copies: Available from the Registered Nurses' Association of Ontario (RNAO), Nursing Best Practice Guidelines Project, 158 Pearl Street, Toronto, Ontario M5H 1L3.

AVAILABILITY OF COMPANION DOCUMENTS

The following are available:

PATIENT RESOURCES

The following is available:

  • Health education fact sheet. You and your IV. Toronto (ON): Registered Nurses' Association of Ontario (RNAO); 2006 Nov. 2 p.

Electronic copies: Available in Portable Document Format (PDF) from the RNAO Web site (French and English).

Print copies: Available from the Registered Nurses' Association of Ontario (RNAO), Nursing Best Practice Guidelines Project, 158 Pearl Street, Toronto, Ontario M5H 1L3.

Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.

NGC STATUS

This NGC summary was completed by ECRI on July 12, 2005. The information was verified by the guideline developer on July 18, 2005. This summary was updated by ECRI Institute on June 22, 2007 following the U.S. Food and Drug Administration (FDA) advisory on heparin sodium injection. This summary was updated by ECRI Institute on March 14, 2008 following the updated FDA advisory on heparin sodium injection. This NGC summary was updated by ECRI Institute on October 30, 2008. The updated information was verified by the guideline developer on November 14, 2008.

COPYRIGHT STATEMENT

With the exception of those portions of this document for which a specific prohibition or limitation against copying appears, the balance of this document may be produced, reproduced, and published in its entirety only, in any form, including in electronic form, for educational or non-commercial purposes, without requiring the consent or permission of the Registered Nurses' Association of Ontario, provided that an appropriate credit or citation appears in the copied work as follows:

Registered Nurses' Association of Ontario (2008). Care and maintenance to reduce vascular access. (rev. suppl.) Toronto, Canada: Registered Nurses' Association of Ontario.

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo